Abstract
In the previous chapter, a cost benefit analysis of six medications was performed- That exercise was useful in providing information in decision-making about listing individual medication on the Pharmaceutical Benefit Scheme (PBS) in Australia. However, a realistic exercise of health programs evaluation should also be in the form of proactive health sector planning. In health sector planning, a set of health programs is chosen from alternatives to be financed by the available budget. In this chapter, we develop a PBS sub-sector planning. We apply the new3 cost benefit analysis developed in Chapter 3 to sub-sector planning of PBS (we call it PBS planning), and discuss the implications of PBS sub-sector planning in selecting a set of medications for PBS listing that can maximise health and social welfare of the society.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Copyright information
© 2006 Sardar M.N. Islam and Christine Suet Yee Mak
About this chapter
Cite this chapter
Islam, S.M.N., Mak, C.S.Y. (2006). PBS Planning: Modelling and Implications. In: Normative Health Economics. Palgrave Macmillan, London. https://doi.org/10.1057/9780230289055_7
Download citation
DOI: https://doi.org/10.1057/9780230289055_7
Publisher Name: Palgrave Macmillan, London
Print ISBN: 978-1-349-54151-5
Online ISBN: 978-0-230-28905-5
eBook Packages: Palgrave Economics & Finance CollectionEconomics and Finance (R0)